K063318 is an FDA 510(k) clearance for the MONOLISA ANTI-HAV EIA. Classified as Hepatitis A Test (antibody And Igm Antibody) (product code LOL), Class II - Special Controls.
Submitted by Bio-Rad Laboratories (Hauts-De-Seine, FR). The FDA issued a Cleared decision on May 3, 2007 after a review of 182 days - an extended review cycle.
This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3310 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.